CurrentCardio
Get Weekly

Topic · page 10 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 361–400 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. JACC Heart Fail

    Long-Term Outcomes From a Decade of Donation After Circulatory Death Heart Transplantation in Australia

    Cohort study

  2. JACC Heart Fail

    Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy

    Cohort study

  3. ESC Heart Fail

    High-urgency heart transplantation and outcome trade-offs: early post-transplant infection and mortality

    Cohort study

  4. Eur Heart J Cardiovasc Pharmacother

    Longitudinal loop diuretic use in patients with HFrEF initiated with sodium–glucose cotransporter 2 inhibitors

    Cohort study

  5. Am Heart J

    Clinical profiles to guide decongestion in acute heart failure

    Meta-analysis

  6. ESC Heart Fail

    Cardiac magnetic resonance imaging parameters predict new-onset symptoms of heart failure in hypertrophic cardiomyopathy

    Cohort study

  7. JAMA

    Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry

    Cohort study

  8. Heart

    Independent prognostic value of left ventricular stroke volume index in patients with takotsubo syndrome: insights from the EVOLUTION registry

    Cohort study

  9. Heart

    Safety and efficacy of mavacamten in obstructive versus non-obstructive hypertrophic cardiomyopathy: a meta-analysis of randomised controlled trials

    Meta-analysis

  10. Nat Med

    Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

    Secondary analysis

  11. ESC Heart Fail

    Predicted versus observed outcomes in the ALT-FLOW early feasibility study

    Secondary analysis

  12. Heart Rhythm

    Prognostic value of the baseline CAVIAR response score after cardiac resynchronization therapy: 10-year outcomes from the Markers and Response to CRT study

    Cohort study

  13. ESC Heart Fail

    Global trend and predictors of non-labelled sacubitril–valsartan dosing: results from IKNOW-HF survey

    Cross-sectional study

  14. ESC Heart Fail

    Efficacy of ARNIs on hard renal outcomes in heart failure with and without chronic kidney disease: when endpoint definition matters—an updated meta-analysis

    Meta-analysis

  15. JACC Heart Fail

    Donor-Derived Cell-Free DNA as a Prognostic Biomarker After Heart Transplantation: The DEFINE-HT Study

    Cohort study

  16. JACC Heart Fail

    Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II

    Secondary analysis

  17. ESC Heart Fail

    Oxygen utilization during moderate-intensity resistance and aerobic exercise in arrhythmogenic cardiomyopathy: the central role of the periphery

    Research article

  18. Eur J Heart Fail

    Bridging the gap: adapting heart failure guidelines for resource-limited settings: A European Journal of Heart Failure expert consensus document

    Guideline or statement

  19. ESC Heart Fail

    Reported decision-making regarding diuretic use and urinary sodium monitoring in acute heart failure: a vignette-based survey in three European countries

    Cross-sectional study

  20. Am Heart J

    Toward developing a patient reported outcomes measure for children with heart failure: A qualitative study design

    Research article

  21. Am Heart J

    Cardio-kidney-metabolic overlap in patients with severe heart failure: Data from the HELP-HF registry

    Cohort study

  22. JACC Adv

    Pregnancy-Associated Cardiomyopathy and Long-Term Cardiac Phenotype in Women With Truncating Titin Variants

    Cohort study

  23. Circ Popul Health Outcomes

    Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review

    Meta-analysis

  24. Eur Heart J Qual Care Clin Outcomes

    Affordability of innovation: cost-effectiveness and budget impact analysis of acoramidis in transthyretin amyloid cardiomyopathy in the German healthcare system

    Cohort study

  25. Eur Heart J Cardiovasc Imaging

    Comparison of the 2016 ASE/EACVI and 2025 ASE guidelines for assessing left atrial pressure in patients with normal left ventricular ejection fraction

    Diagnostic or prognostic study

  26. JAMA Cardiol

    Artificial Intelligence Electrocardiogram and Left Ventricular Systolic Dysfunction in Kenya

    Diagnostic or prognostic study

  27. JAMA Cardiol

    Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  28. JAMA Cardiol

    Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial

    Randomised controlled trial

  29. JAMA Cardiol

    Myocardial Fibroblast Activation in Ischemic and Nonischemic Cardiomyopathy

    Case-control study

  30. JAMA Cardiol

    Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction

    Cohort study

  31. JAMA Cardiol

    Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population

    Cohort study

  32. Heart Rhythm

    Determinants and outcomes of late electrical storm in patients supported by left ventricular assist device

    Cohort study

  33. Eur J Heart Fail

    Baseline characteristics of patients with transthyretin amyloid cardiomyopathy in the CARDIO-TTRansform trial of eplontersen

    Randomised controlled trial

  34. Eur Heart J

    Prevention of heart failure

    Guideline or statement

  35. ESC Heart Fail

    Comparative analysis of randomized versus real-world populations in heart failure: DIAMOND trial vs CARE-HK registry

    Randomised controlled trial

  36. ESC Heart Fail

    Evaluating the temporal and sociodemographic generalizability of the emergency heart failure mortality risk grade

    Diagnostic or prognostic study

  37. Eur J Heart Fail

    Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: findings from ATTRibute-CM

    Secondary analysis

  38. Heart

    COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype

    Cohort study

  39. Heart

    Prognostic value of pulmonary transit time by cardiovascular MRI in heart failure with preserved ejection fraction

    Cohort study

  40. Circulation

    Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association

    Guideline or statement

All 1,928 Briefs in ExploreShowing Briefs 361–400 of 1,928, newest first